Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

d responds to a certain interaction partner such as hormones, immune mediators or other
substances.
Renin: enzyme that catalyzes the formation of angiotensin I (Ang I) from its precursor angiotensinogen and thus initiates the reninangiotensin
system cascade.
Run-in period: time window during which blood pressure monitoring devices are placed at the participants by specialized staff and first
measurements begin. During this time window blood pressure values can be influenced by the general handling and the contact with the
doctor (so called “white coat effect”).
SBP: systolic blood pressure.
Small molecule drugs: low molecular weight chemical compounds. Many pharmaceutical drugs are small molecules.
Stroke: a sudden interruption in the blood supply of the brain. Most strokes are caused by an abrupt blockage of arteries leading to the
brain; others are caused by bleeding into brain tissue when a blood vessel bursts (see also intracerebral hemorrhage).
Systolic blood pressure: the highest pressure within the arterial blood stream occurring during each heart beat. “Systolic” refers to the
contraction of the heart muscle.
Therapeutic vaccine: a preparation of disease-related molecules (antigens) of foreign or self origin that is capable of activating the
immune system against such antigens with the goal to modulate disease processes.
This foregoing press release may contain forward-looking statements that include words or phrases such as “potentially”, “may”, “would”, “suggest”,
“should”, “might”, “designed”, “intend” or other similar expressions. These forward-looking statements are subject to a variety of significant
uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly fro
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Regulatory ... and government, where regulations are often strict and ... is driving a demand for professionals who have ... these regulations across a product lifecycle and demonstrate ... The University of California, Irvine Extension , ...
(Date:8/31/2015)... , August 31, 2015 ... (TASE: BOLT, OTCQX: BLGTY) ("BioLight" or the "Company"), ... biomedical innovations in ophthalmology and cancer diagnostics, today ... (TASE: MCTC), has identified several new genetic markers ... jawbone in patients treated with bisphosphonate drugs and ...
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4
... Plus, Higher then Expected MCI Prevalence Shows Urgent ... Two studies related to,experimental Alzheimer,s therapies reported ... Conference on Alzheimer,s,Disease (ICAD 2008) in Chicago., ... AL-108, targeted early,abnormal brain changes in a protein ...
... July 28 Cardium Therapeutics,(Amex: CXM ) ... as Chief,Medical Officer to lead the Company,s late-stage ... the MATRIX Phase 2b,clinical study that is evaluating ... ulcers, and the AWARE Phase 3 clinical study ...
Cached Medicine Technology:Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 2Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 3Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 4Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 5Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 6Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 2Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 3Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 4Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 5
(Date:8/31/2015)... ... August 31, 2015 , ... ... may be at a greater risk for injury, potentially because they are more ... of Pittsburgh Graduate School of Public Health analysis discovered. , The research, ...
(Date:8/31/2015)... York, NY (PRWEB) , ... August 31, 2015 ... ... simulations that enable users to develop skills and assess their competencies in managing ... of research, will present at the Defense Centers of Excellence for Psychological ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... On ... With A Mission” at the Adams County Fairgrounds in Mendon, IL. The purpose behind ... school districts of Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music ...
(Date:8/31/2015)... ... August 31, 2015 , ... The German soccer league (DFL ... (CMS) and make website updates quicker and more flexible. The company's CMS solution ... Bundesliga (the German equivalent of the U.S. Soccer Federation) more modern, exciting and ...
(Date:8/31/2015)... ... ... “My mother and husband use oxygen therapy and the tubing irritates the ... be a comfortable way to prevent the irritation, so I invented this.” She invented ... secure way to anchor the cannula tubing used in oxygen therapy and it prevents ...
Breaking Medicine News(10 mins):Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2
... Recent research has revealed that women aged 60 and ... heart attack compared to others. The results of the ... such patients when compared to heart attack patients who ... been published in the April 24 issue of the ...
... Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, ... Shipments of pravastatin sodium tablets// have been started ... mg strengths. ,Watson Pharmaceuticals, Inc. has ... leading specialty pharmaceutical company that specializes in the ...
... Pyszczynski, professor, Psychology, University of Colorado at Colorado ... Zarand, //Iran, Sheldon Solomon, professor, Psychology, Skidmore College, ... University of Arizona, Tuscon. , In ... were questioned and were found that thoughts of ...
... practice followed is to begin immunizations of babies at two ... not achieve// the desired purpose, due to the incapacity of ... the vaccines. Now, according to a new study conducted by ... response in newborns, with a certain type of molecule present ...
... Health Organization (WHO) is in the process of updating the ... the new one, which will present// the rates at which ... form. ,The 20-year old charts are said to ... revision is based on growth data from breast-fed babies who ...
... of two decades ago still holds more than a third ... here still continues// to cause cancer in children according to ... ,According to official measurements published in the report at least ... for centuries as a result of the disaster. ...
Cached Medicine News:Health News:Depression Accompanies Heart Attacks in Younger Women 2
... with Tim™ (Total imaging matrix) technology ... and highest resolution at 3T. With ... advanced applications can now be translated ... with Tim is an excellent dual-purpose ...
... Billing Assistant (MBA) is a ... and practice management software package. ... SQL Server technology and is ... and account receivable management, MBA ...
... a practice management system. DAQbilling files all ... Your patient statements can also be printed and ... traditional software and billing services into one software ... anywhere - multiples offices or home. ...
... G-3 goniofundus lens incorporate 3 mirrors angled at ... ideal for anterior chamber as well as central ... retinal viewing mirrors are accurately angled and spaced ... fundus. The central portion of the lens ...
Medicine Products: